Predict your next investment

HEALTHCARE | Biotechnology
novolytics.co.uk

See what CB Insights has to offer

About Novolytics

Novolytics, formed in 2002, engages in the research, development, and production of phage therapy products to combat antibiotic resistance.

Novolytics Headquarter Location

Sumner House St. Thomas's Road

Lancashire, England, PR7 1HP,

United Kingdom

Latest Novolytics News

AmpliPhi Acquires Key Bacteriophage Assets from UKbased Novolytics

Jan 13, 2016

AmpliPhi announces pre-clinical data M. Scott Salka, CEO of AmpliPhi Biosciences, said: “These Novolytics assets will broaden our IP portfolio and speed the development of our phage therapies. This acquisition supports our strategy of assembling the premier bacteriophage therapy company through the acquisition of world-class talent and assets to accomplish our goal of arming physicians and patients with novel and effective weapons against the growing threat of antibiotic-resistant pathogens.” Previous AmpliPhi acquisitions include Biocontrol of London, UK, acquired in late 2010, and Special Phage Services, of Sydney, Australia, acquired in late 2012. AmpliPhi maintains a research and development facility in Sydney, and, as a direct result of earlier relationships forged by Special Phage Services with Flinders and Adelaide Universities in South Australia, expects to soon be dosing chronic rhinosinusitis patients in its first clinical trial of a phage therapeutic at the Queen Elizabeth Hospital in Adelaide.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Novolytics Patents

Novolytics has filed 2 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/7/2012

4/18/2017

Bacteriophages, Molecular biology, Antibiotics, Virology, Virus families

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

11/7/2012

00/00/0000

Grant Date

4/18/2017

00/00/0000

Title

Subscribe to see more

Related Topics

Bacteriophages, Molecular biology, Antibiotics, Virology, Virus families

Subscribe to see more

Status

Grant

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.